Wearable technology company Ultrahuman has partnered with period tracking app Clue to offer integrated cycle and biomarker monitoring. The collaboration includes a full year of Clue Plus for $9.99 with every Ultrahuman Ring AIR purchase, reduced from the standard $39.99 price.
The partnership allows users to connect their Clue account with Ultrahuman’s Ring AIR to automatically import up to six months of cycle history alongside real-time biomarker data including heart rate variability, resting heart rate, and skin temperature. This integration eliminates the need for manual data entry across multiple platforms.
Clue Plus provides personalized cycle tracking, hormone insights, advanced predictions, and features designed for pregnancy and perimenopause. The service also includes 12-month forecasting and clinical guidance to help users understand their reproductive health patterns.
“This collaboration is about providing women with choice and confidence in their health journey,” said Kate Davies, VP Medical, Women’s Health & Longevity at Ultrahuman. “By combining the biomarker insights of the Ring AIR with Clue Plus, we are enabling seamless, cycle-aware health tracking that helps women reflect on their bodies with greater ease.”
The integration aims to provide a comprehensive view of women’s health by combining menstrual cycle patterns with daily physiological measurements. Users can view correlations between their cycle phases and biomarker changes without logging data separately in multiple applications.
“At Clue, we want to see a world where women live better,” said Rhiannon White, CEO at Clue. “Partnering with Ultrahuman allows us to further deepen the rich dataset women build in the Clue app, empowering them to take control of their own health and live the lives they envisage for themselves.”
The partnership builds on Ultrahuman’s recent acquisition of viO HealthTech, creators of the clinically validated OvuSense fertility algorithm, demonstrating continued investment in women’s health technology. The collaboration is available across all Ultrahuman markets starting September 15.
